Welcome to LookChem.com Sign In|Join Free
  • or
BOC-1,2-TRANS-ACHC-OH is a chemical with a specific purpose. Lookchem provides you with multiple data and supplier information of this chemical.

209128-50-7

Post Buying Request

209128-50-7 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

209128-50-7 Usage

Chemical Properties

White crystalline powder

Check Digit Verification of cas no

The CAS Registry Mumber 209128-50-7 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 2,0,9,1,2 and 8 respectively; the second part has 2 digits, 5 and 0 respectively.
Calculate Digit Verification of CAS Registry Number 209128-50:
(8*2)+(7*0)+(6*9)+(5*1)+(4*2)+(3*8)+(2*5)+(1*0)=117
117 % 10 = 7
So 209128-50-7 is a valid CAS Registry Number.
InChI:InChI=1/C12H21NO4/c1-12(2,3)17-11(16)13-9-7-5-4-6-8(9)10(14)15/h8-9H,4-7H2,1-3H3,(H,13,16)(H,14,15)/t8-,9-/m1/s1

209128-50-7 Well-known Company Product Price

  • Brand
  • (Code)Product description
  • CAS number
  • Packaging
  • Price
  • Detail
  • Alfa Aesar

  • (H62007)  trans-2-(Boc-amino)cyclohexanecarboxylic acid, 97%   

  • 209128-50-7

  • 250mg

  • 274.0CNY

  • Detail
  • Alfa Aesar

  • (H62007)  trans-2-(Boc-amino)cyclohexanecarboxylic acid, 97%   

  • 209128-50-7

  • 1g

  • 823.0CNY

  • Detail
  • Alfa Aesar

  • (H62007)  trans-2-(Boc-amino)cyclohexanecarboxylic acid, 97%   

  • 209128-50-7

  • 5g

  • 3293.0CNY

  • Detail
  • Aldrich

  • (29293)  trans-2-(Boc-amino)-cyclohexanecarboxylicacid  ≥98.0% (TLC)

  • 209128-50-7

  • 29293-1G-F

  • 2,501.46CNY

  • Detail

209128-50-7Relevant academic research and scientific papers

Structure - Activity studies of 14-helical antimicrobial β-peptides: Probing the relationship between conformational stability and antimicrobial potency

Raguse, Tami L.,Porter, Emilie A.,Weisblum, Bernard,Gellman, Samuel H.

, p. 12774 - 12785 (2002)

Antimicrobial α-helical α-peptides are part of the host-defense mechanism of multicellular organisms and could find therapeutic use against bacteria that are resistant to conventional antibiotics. Recent work from Hamuro et al. has shown that oligomers of

Polysilane-Immobilized Rh-Pt Bimetallic Nanoparticles as Powerful Arene Hydrogenation Catalysts: Synthesis, Reactions under Batch and Flow Conditions and Reaction Mechanism

Miyamura, Hiroyuki,Suzuki, Aya,Yasukawa, Tomohiro,Kobayashi, Shu

supporting information, p. 11325 - 11334 (2018/09/06)

Hydrogenation of arenes is an important reaction not only for hydrogen storage and transport but also for the synthesis of functional molecules such as pharmaceuticals and biologically active compounds. Here, we describe the development of heterogeneous Rh-Pt bimetallic nanoparticle catalysts for the hydrogenation of arenes with inexpensive polysilane as support. The catalysts could be used in both batch and continuous-flow systems with high performance under mild conditions and showed wide substrate generality. In the continuous-flow system, the product could be obtained by simply passing the substrate and 1 atm H2 through a column packed with the catalyst. Remarkably, much higher catalytic performance was observed in the flow system than in the batch system, and extremely strong durability under continuous-flow conditions was demonstrated (>50 days continuous run; turnover number >3.4 × 105). Furthermore, details of the reaction mechanisms and the origin of different kinetics in batch and flow were studied, and the obtained knowledge was applied to develop completely selective arene hydrogenation of compounds containing two aromatic rings toward the synthesis of an active pharmaceutical ingredient.

Solid-phase synthesis of 6,7-cycloalkane-fused 1,4-diazepane-2,5-diones via a cyclization/release strategy

Caroen, Jurgen,Clemmen, An,Kámán, Judit,Backaert, Fréderique,Goeman, Jan L.,Fül?p, Ferenc,Van Der Eycken, Johan

, p. 148 - 160 (2015/12/23)

A solid-phase synthesis procedure for the parallel preparation of 6,7-cycloalkane-fused 1,4-diazepane-2,5-diones is described. The methodology applies α- and alicyclic β-amino acid building blocks to construct the seven-membered heterocyclic core, while a

PYRIDIN-2 (1H) -ONE DERIVATIVES USEFUL AS MEDICAMENTS FOR THE TREATMENT OF MYELOPROLIFERATIVE DISORDERS, TRANSPLANT REJECTION, IMMUNE-MEDIATED AND INFLAMMATORY DISEASES

-

Page/Page column 97, (2012/12/13)

Compoundshaving the chemical structure of formula (I) are disclosed; as well as process for theirpreparation, pharmaceutical compositions comprising them and their use in therapy as inhibitors of Janus Kinases (JAK).

2-Aminomethylphenylamine as a novel scaffold for factor Xa inhibitor

Mochizuki, Akiyoshi,Nagata, Tsutomu,Kanno, Hideyuki,Suzuki, Makoto,Ohta, Toshiharu

scheme or table, p. 1623 - 1642 (2011/04/21)

We have been researching orally active factor Xa inhibitor for a long time. We explored the new diamine linker using effective ligands to obtain a new attractive original scaffold 2-aminomethylphenylamine derivative. Compound 1D showed very strong in vitro and in vivo factor Xa inhibitory activity, as well as favorable PK profiles in po administration to monkeys.

PIPERIDINE DERIVATIVES AS MODULATORS OF CHEMOKINE RECEPTOR ACTIVITY

-

Page/Page column 70-71, (2009/03/07)

The present application describes modulators of MIP-1 of formula (I) : or stereoisomers or pharmaceutically acceptable salts thereof, wherein m, Q, T, W, Z, R1, R3, R4, R5, R5a and R5b, are as set forth above. In addition, methods of treating and preventing inflammatory diseases such as asthma and allergic diseases, as well as autoimmune pathologies such as rheumatoid arthritis and atherosclerosis using the modulators are disclosed.

Parallel assembly of dipolar columns composed of a stacked cyclic tri-β-peptide

Fujimura, Futoshi,Fukuda, Makoto,Sugiyama, Junji,Morita, Tomoyuki,Kimura, Shunsaku

, p. 1896 - 1901 (2008/09/18)

A novel cyclic trimer of a β-amino acid, trans-2- aminocyclohexylcarboxylic acid, was synthesized and its conformation and ability to form assemblies investigated. FT-IR and NMR measurements and computational calculations showed that this cyclic tri-β-pep

Heterogeneous foldamers containing alpha, beta, and/or gamma-amino acids

-

, (2008/06/13)

Disclosed are isolated, unnatural polypeptides containing cyclically-constrained β-amino acid residues and cyclically-constrained γ-amino acid residues. The compounds are unnatural and because they contain rotationally constrained residues that are not amenable to enzymatic degradation, the compounds are useful to probe protein-protein and other large molecule interactions.

Benzamide nitriles

-

Page 39, (2010/02/09)

Compounds of the formula (I) wherein m, n, A, R1, R2, R3, R4, R5 and R6 are as described herein, together with methods for making the compounds and using the compounds for treatment of diseases or conditions mediated by Cathepsin K.

Benzene-fused heterocycle derivatives and drugs containing the same as the active ingredient

-

, (2008/06/13)

A benzene-fused heteroring derivative of formula (I) 1, wherein all symbols are the same as described in the specification, and a non-toxic salt thereof. The compound of formula (I) has an inhibitory activity against cysteine protease and therefore it is

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 209128-50-7